Emergent BioSolutions, Inc.
2273 Research Blvd., Suite 400
Rockville, MD 20850
About Emergent BioSolutions, Inc.
- Emergent BioSolutions Inc. is a biopharmaceutical company dedicated to one simple mission – to protect life. We develop, manufacture and commercialize immunobiotics, consisting of vaccines and therapeutics that assist the body’s immune system to prevent or treat disease. Our biodefense business focuses on immunobiotics for use against biological agents that are potential weapons of bioterrorism and biowarfare. Our marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax infection. Our commercial business focuses on immunobiotics for use against infectious diseases and other medical conditions that have resulted in significant unmet or underserved public health needs.
Competitors of Emergent BioSolutions, Inc.
QuickSilver Analytics, Inc.
QS manufactures CBRNE forensic quality sampling kits. We are a SDVOB and manufacture IAW ISO 9001-2008.
Products by Emergent BioSolutions, Inc.
RSDL
RSDecon is a brand of products manufactured by the Healthcare Protective Products Division (HPPD) of Bracco Diagnostics Inc., the exclusive global manufacturer and marketer of RSDL. RSDL is a patented, broad spectrum skin decontamination product intended to neutralize or remove chemical warfare... Read more